Form D — Verismo Therapeutics, Inc.
0001855431-26-000003 · filed May 20, 2026
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $28,000,000
- Total sold
- $28,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Verismo Therapeutics, Inc.
- CIK
- 1855431
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3675 Market Street, Suite 200
Philadelphia, PA 19104 - Phone
- 609-790-5188
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gene Kim · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Bryan B. Kim · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Yang Gon Jin · DirectorPhiladelphia, PA Find on LinkedIn ↗
-
Jong Sun Yoon · DirectorPhiladelphia, PA Find on LinkedIn ↗
-
Dong Gun Kim · DirectorPhiladelphia, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗